Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars

Status unconfirmed

Conditions studied: Keloid Scar

In brief

Keloid formation in response to skin trauma inflicts about 18 million individuals. A key impediment in successful treatment of keloids is that the predominant treatments, particularly surgical excision and shaving, tend to initiate the regrowth of the keloid at the excision site, and therefore, recurrence rates are high. There is much evidence to demonstrate that following surgical excision procedures with a course of radiation therapy can significantly reduce recurrence rates to as little as 10% or below. This prospective study is to evaluate this claim.

Key facts

Study ID

NCT04184011

Run by

Sensus Healthcare

People needed

100

Starts

2019-08-15

Expected to finish

2020-08-16

Last updated by the study team

2019-12-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of keloid(s)
• Independently scheduled for treatment with SRT-100™, SRT-Vision™ or SRT-100+™ for one or more keloids
• Subject voluntary provides written consent to be in the study

You may not qualify if…

• Lesions of etiology other than keloids
• Any factor(s) that in the professional opinion of the investigator warrants the individual unsuitable for study participation

Where it is running

• Dermatology and Dermatological Surgery — Boynton Beach, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.